Filed: 2/17/2026ACC: 0000905148-26-000841
📋 What this filing means
VENBIO PARTNERS LLC filed this quarterly 13F‑HR report disclosing 6 equity positions with a total reported market value of $216.27M. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
6
Positions
$216.27M
Total AUM (reported)
20.43M
Total Shares
Allocation by class
COM$205.88M95.2%
COM NEW$10.39M4.8%
Portfolio Concentration
Top 3$192.14M88.8%
4–10$24.14M11.2%
Top 3 weight
88.8%
Top 10 weight
100.0%
Voting Authority Distribution
Total shares with voting rights: 20.43M
Sole
Full voting authority
20.43M
shares
% of voting shares100.0%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole6
Shared0
Other0
Dominant voting typeSole · 100.0% of voting shares
Institutional Holdings6
Rows:
PHARVARIS N V
SOLEShares4.64M
TypeSH
Market value$128.74M
59.53%
Sole
4.64M
Shared
0.00
None
0.00
ALUMIS INC
SOLEShares4.62M
TypeSH
Market value$45.09M
20.85%
Sole
4.62M
Shared
0.00
None
0.00
HARMONY BIOSCIENCES HLDGS IN
SOLEShares489.19K
TypeSH
Market value$18.31M
8.46%
Sole
489.19K
Shared
0.00
None
0.00
ALX ONCOLOGY HLDGS INC
SOLEShares9.70M
TypeSH
Market value$10.96M
5.07%
Sole
9.70M
Shared
0.00
None
0.00
LYELL IMMUNOPHARMA INC
SOLEShares337.70K
TypeSH
Market value$10.39M
4.81%
Sole
337.70K
Shared
0.00
None
0.00
ARTIVA BIOTHERAPEUTICS INC
SOLEShares648.51K
TypeSH
Market value$2.78M
1.29%
Sole
648.51K
Shared
0.00
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
PHARVARIS N VSOLE | COM | 4.64M | SH | $128.74M 59.53% | 4.64M | 0.00 | 0.00 |
ALUMIS INCSOLE | COM | 4.62M | SH | $45.09M 20.85% | 4.62M | 0.00 | 0.00 |
HARMONY BIOSCIENCES HLDGS INSOLE | COM | 489.19K | SH | $18.31M 8.46% | 489.19K | 0.00 | 0.00 |
ALX ONCOLOGY HLDGS INCSOLE | COM | 9.70M | SH | $10.96M 5.07% | 9.70M | 0.00 | 0.00 |
LYELL IMMUNOPHARMA INCSOLE | COM NEW | 337.70K | SH | $10.39M 4.81% | 337.70K | 0.00 | 0.00 |
ARTIVA BIOTHERAPEUTICS INCSOLE | COM | 648.51K | SH | $2.78M 1.29% | 648.51K | 0.00 | 0.00 |